Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 68,974 shares at $53.98 ($5.2M) on 2017-02-27, disclosed to the SEC on 2017-03-01.
Open-market sale of $5.2M KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.15 | 4,400 | $234K | 4.5% |
| 2 | $53.98 | 1,210 | $65K | 1.2% |
| 3 | $53.98 | 1,210 | $65K | 1.2% |
| 4 | $54.91 | 1,800 | $99K | 1.9% |
| 5 | $56.29 | 1,900 | $107K | 2.0% |
| 6 | $56.83 | 690 |
| $39K |
| 0.7% |
| 7 | $80.05 | 28,882 | $2.3M | 44.2% |
| 8 | $80.05 | 28,882 | $2.3M | 44.2% |
| Total | $75.88 avg | 68,974 | $5.2M | 100% |
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |
| KITE | SELL | 2017-06-12 | $885K | — | Filing → |